Accolade Inc. Stock News

Accolade, Inc. (NASDAQ:ACCD) Q1 2021 Earnings Conference Call August 13, 2020 5:00 PM ET Company Participants Rajeev Singh – Chief Executive Officer Steve Barnes – Chief Financial Officer Conferen

* Fiscal first quarter 2021 revenue of $35.9 million, a 25% increase compared to fiscal first quarter 2020 revenue of $28.8 million, driven primarily by strength in new customer adds across segments a

A major shift into tech/growth stocks occurred due to the COVID-19 pandemic with the Nasdaq being up 18% YTD. I anticipate that this trend will reverse soon.

SEATTLE, July 27, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the health

Seven IPOs and one SPAC plan to raise $2.1 billion in the week ahead, led by tax software provider Vertex.

Starboard Value increased its position in pediatric and neonatal health-services firm Mednax. Carrick Management Partners disclosed an initial investment of 3,508,278 shares in Accolade, a newly publi

Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, t

Accolade operates at the intersection of tech and healthcare, an interesting environment to operate in. I see the potential for the business as the company has

Three IPOs raised $2.3 billion this past week, led by Dun & Bradstreet's billion-dollar deal. All three IPOs upsized their deals and priced above the range. Lem

Accolade, Inc. ("Accolade"), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, tod

Four IPOs are expected to raise $2 billion before the Fourth of July, led by commercial data analytics provider Dun & Bradstreet. Insurtech startup Lemonade pla

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th

Accolade intends to raise $175 million in a U.S. IPO. The firm provides a healthcare management and relationship platform to enterprises. ACCD has grown revenue

Accolade has filed to raise $100 million in an IPO, although the final figure may differ. The firm has developed an integrated healthcare and wellness platform